| Cwh Regional Eye Center | |
| 933 Red Apple Rd, Wenatchee, Washington 98801 | |
| (509) 663-8711 |
| Name | Cwh Regional Eye Center |
|---|---|
| Organization Name | Central Washington Health Services Association |
| Location | 933 Red Apple Rd, Wenatchee, Washington 98801 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (509) 663-8711 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Prior neuroimaging studies have shown alcoholism-related damage to the frontal lobes and cerebellum.
University at Buffalo researchers received an $880,000 grant to help quicken the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus, such as by intrauterine devices
For the first time, two advanced biophotonic technologies – near-infrared time-resolved spectroscopy (TRS) and diffuse correlation spectroscopy (DCS) – have been combined and the already tested prototypes were extended to the level of demonstrators.
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
This study demonstrates that over 6 weeks of treatment, patients with melancholic depression and medical comorbidity (MC) (specifically cardiovascular or endocrinological MC) had poorer treatment response and a worse functional outcome as opposed to their counterparts without MC. Interestingly, these effects were not related to various antidepressant treatment regimens.
› Verified 3 days ago
| NPI Number | 1639734320 |
| Organization Name | WENATCHEE VALLEY HOSPITAL |
| Doing Business As | CONFLUENCE HEALTH WENATCHEE VALLEY HOSPITAL & CLINICS |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1000b N Miller St, Wenatchee, WA 98801 |
| Phone Number | 509-663-8711 |
News Archive
Prior neuroimaging studies have shown alcoholism-related damage to the frontal lobes and cerebellum.
University at Buffalo researchers received an $880,000 grant to help quicken the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus, such as by intrauterine devices
For the first time, two advanced biophotonic technologies – near-infrared time-resolved spectroscopy (TRS) and diffuse correlation spectroscopy (DCS) – have been combined and the already tested prototypes were extended to the level of demonstrators.
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
This study demonstrates that over 6 weeks of treatment, patients with melancholic depression and medical comorbidity (MC) (specifically cardiovascular or endocrinological MC) had poorer treatment response and a worse functional outcome as opposed to their counterparts without MC. Interestingly, these effects were not related to various antidepressant treatment regimens.
› Verified 3 days ago
News Archive
Prior neuroimaging studies have shown alcoholism-related damage to the frontal lobes and cerebellum.
University at Buffalo researchers received an $880,000 grant to help quicken the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus, such as by intrauterine devices
For the first time, two advanced biophotonic technologies – near-infrared time-resolved spectroscopy (TRS) and diffuse correlation spectroscopy (DCS) – have been combined and the already tested prototypes were extended to the level of demonstrators.
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
This study demonstrates that over 6 weeks of treatment, patients with melancholic depression and medical comorbidity (MC) (specifically cardiovascular or endocrinological MC) had poorer treatment response and a worse functional outcome as opposed to their counterparts without MC. Interestingly, these effects were not related to various antidepressant treatment regimens.
› Verified 3 days ago
Sav-on Pharmacy #3412 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1128 N Miller St, Wenatchee, Washington 98801 Phone: (509) 662-5152 | |
Bellevue Healthcare Ii Inc Central Type: Durable Medical Equipment & Medical Supplies Supplier Location: 223 S Wenatchee Ave, Wenatchee, Washington 98801 Phone: (509) 662-8700 | |
Central Washington Hospital Type: Pharmacy Location: 1201 S Miller St, Wenatchee, Washington 98801 Phone: (509) 665-6096 | |
Central Washington Hospital Profess Type: Medicare Supplier Location: 1201 S Miller St, Wenatchee, Washington 98801 Phone: (509) 667-3333 | |
Cwh Regional Eye Center Type: Durable Medical Equipment & Medical Supplies Supplier Location: 933 Red Apple Rd, Wenatchee, Washington 98801 Phone: (509) 663-8711 |